Product Information
MINOCYCLINE 50 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1801 per EA under NDC 68382031601. Its NADAC has been published 484 times since Jun 28, 2017.
FDA first approved this application on Mar 2, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382031601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA063011FDA Approved
3/2/1992
TE Code
AB
On Market Since
4/3/2017
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE 50 MG CAPSULE has been published 484 times since Jun 28, 2017, and over the history we have for it it has declined 25.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1801 per EA |
|---|---|
| All-time high | $0.2619 (Aug 16, 2017) |
| All-time low | $0.1446 (Jul 17, 2024) |
| 52-week high | $0.1814 |
| 52-week low | $0.1748 |
| Median price | $0.1929 |
| Average price | $0.1950 |
| Largest weekly change | -22.5% (Nov 20, 2024) |
| Weeks tracked | 484 |
| Tracking since | Jun 28, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Minocycline hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Minocycline hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MINOCYCLINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE 50 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1801 per EA (NDC 68382031601), effective Sep 30, 2026.
How has the price of MINOCYCLINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE 50 MG CAPSULE has declined 25.2%. It has been tracked across 484 weekly CMS publications since Jun 28, 2017.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE 50 MG CAPSULE?
Since Jun 28, 2017, the NADAC for MINOCYCLINE 50 MG CAPSULE has ranged from a low of $0.1446 (Jul 17, 2024) to a high of $0.2619 (Aug 16, 2017), with a median of $0.1929 per EA.
Are there cheaper alternatives to MINOCYCLINE 50 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of MINOCYCLINE 50 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MINOCYCLINE 50 MG CAPSULE?
MINOCYCLINE 50 MG CAPSULE (NDC 68382031601) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.